Alcon ALC unveiled results from time and motion studies demonstrating superior efficiency with the UNITY Vitreoretinal Cataract System (VCS) for vitreoretinal and cataract surgery compared to the ...

GENEVA--(BUSINESS WIRE)--Regulatory News: Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced that UNITY ® Vitreoretinal Cataract System ...

Combined vitreoretinal-cataract system (VCS) is cleared for use in Canada New, proprietary technology is designed to deliver significant surgical and workflow efficiencies First innovation to be ...

(RTTNews) - Alcon, Inc. (ALC) announced Tuesday that UNITY Vitreoretinal Cataract System (VCS) has received Health Canada approval. This innovation is the first to be introduced from Alcon's highly ...

Alcon Inc.’s ALC UNITY Vitreoretinal Cataract System (“VCS”) has recently received approval from Health Canada. UNITY VCS is the latest innovation from the Alcon Vision Suite — a portfolio of ...

I reiterate a 'Strong Buy' rating for Alcon with a one-year price target of $115 per share, driven by new product pipelines and FDA clearances. Alcon's Unity VCS/CS systems received FDA clearance, set ...

CEO David Endicott pointed to building momentum in the second half of 2025, with particular strength in equipment and ocular health. Endicott highlighted, "the launch [of Unity VCS] is delivering on ...

William Blair initiated coverage on Alcon Inc. (NYSE: ALC) on Friday with a Market Perform rating. Over the past two years, Alcon has been aggressive in driving top-line growth both internally ...